Antiplatelet drug
You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.
|
WikiDoc Resources for Antiplatelet drug | |
|
Articles | |
|---|---|
|
Most recent articles on Antiplatelet drug Most cited articles on Antiplatelet drug | |
|
Media | |
|
Powerpoint slides on Antiplatelet drug | |
|
Evidence Based Medicine | |
|
Cochrane Collaboration on Antiplatelet drug | |
|
Clinical Trials | |
|
Ongoing Trials on Antiplatelet drug at Clinical Trials.gov Trial results on Antiplatelet drug Clinical Trials on Antiplatelet drug at Google
| |
|
Guidelines / Policies / Govt | |
|
US National Guidelines Clearinghouse on Antiplatelet drug NICE Guidance on Antiplatelet drug
| |
|
Books | |
|
News | |
|
Commentary | |
|
Definitions | |
|
Patient Resources / Community | |
|
Patient resources on Antiplatelet drug Discussion groups on Antiplatelet drug Patient Handouts on Antiplatelet drug Directions to Hospitals Treating Antiplatelet drug Risk calculators and risk factors for Antiplatelet drug
| |
|
Healthcare Provider Resources | |
|
Causes & Risk Factors for Antiplatelet drug | |
|
Continuing Medical Education (CME) | |
|
International | |
|
| |
|
Business | |
|
Experimental / Informatics | |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Phone:617-632-7753
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Overview
An antiplatelet drug is a member of a class of pharmaceuticals that decreases platelet aggregation and inhibits thrombus formation. They are effective in the arterial circulation, where anticoagulants have little effect.
They are widely used in primary and secondary prevention of thrombotic cerebrovascular or cardiovascular disease.
The Most Important Antiplatelet Drugs
- COX-2 inhibitor / Cyclooxygenase inhibitors
- Adenosine diphosphate (ADP) receptor inhibitors
- Clopidogrel (Plavix)
- Ticlopidine (Ticlid)
- Phosphodiesterase inhibitors
- Cilostazol (Pletal)
- Glycoprotein IIB/IIIA inhibitors (intravenous use only)
- Abciximab (ReoPro)
- Eptifibatide (Integrilin)
- Tirofiban (Aggrastat)
- Defibrotide
- Adenosine reuptake inhibitors
- Dipyridamole (Persantine)
See also
Major Drug Groups | |
|---|---|
| Gastrointestinal tract (A) | Antacids • Antiemetics • H₂-receptor antagonists • Proton pump inhibitors • Laxatives • Antidiarrhoeals |
| Blood and blood forming organs (B) | Anticoagulants • Antiplatelets • Thrombolytics |
| Cardiovascular system (C) | Antiarrhythmics • Antihypertensives • Diuretics • Vasodilators • Antianginals • Beta blockers • Angiotensin converting enzyme inhibitors • Antihyperlipidemics |
| Skin (D) | Emollients - Antipruritics |
| Reproductive system (G) | Hormonal contraception • Fertility agents • Selective estrogen receptor modulators • Sex hormones |
| Endocrine system (H) | Anti-diabetics • Corticosteroids • Sex hormones • Thyroid hormones |
| Infections and Infestations (J, P) | Antibiotics • Antivirals • Vaccines • Antifungals • Antiprotozoals • Anthelmintics |
| Malignant and Immune disease (L) | Anticancer agents • Immunostimulators • Immunosuppressants |
| Muscles, Bones, and Joints (M) | Anabolic steroids • Anti-inflammatories • Antirheumatics • Corticosteroids • Muscle relaxants |
| Brain and Nervous system (N) | Anesthetics • Analgesics • Anticonvulsants • Mood stabilizers • Anxiolytics • Antipsychotics • Antidepressants • Nervous system stimulants • Sedatives |
| Respiratory system (R) | Bronchodilators • Decongestants • Antihistamines |
WikiDoc Research Resources for Antiplatelet drug | |
|---|---|
| Articles on Antiplatelet drug | Most recent articles on Antiplatelet drug • Most cited articles on Antiplatelet drug • Review articles on Antiplatelet drug • Articles on Antiplatelet drug in N Eng J Med, Lancet, BMJ |
| Media (Slides, Video, Images, MP3) on Antiplatelet drug | Powerpoint slides on Antiplatelet drug • Images of Antiplatelet drug • Photos of Antiplatelet drug • Podcasts & MP3s on Antiplatelet drug • Videos on Antiplatelet drug |
| Evidence Based Medicine Regarding Antiplatelet drug | Cochrane Collaboration on Antiplatelet drug • Bandolier on Antiplatelet drug • TRIP on Antiplatelet drug |
| Cost Effectiveness of Antiplatelet drug | Cost Effectiveness of Antiplatelet drug |
| Clinical Trials Involving Antiplatelet drug | Ongoing Trials on Antiplatelet drug at Clinical Trials.gov • Trial results on Antiplatelet drug • Clinical Trials on Antiplatelet drug at Google |
| Guidelines / Policies / Government Resources (FDA/CDC) Regarding Antiplatelet drug | US National Guidelines Clearinghouse on Antiplatelet drug • NICE Guidance on Antiplatelet drug • NHS PRODIGY Guidance • FDA on Antiplatelet drug • CDC on Antiplatelet drug |
| Textbook Information on Antiplatelet drug | Books and Textbook Information on Antiplatelet drug |
| Pharmacology Resources on Antiplatelet drug | Dosing of Antiplatelet drug • Drug interactions with Antiplatelet drug • Side effects of Antiplatelet drug • Allergic reactions to Antiplatelet drug • Overdose information on Antiplatelet drug • Carcinogenicity information on Antiplatelet drug • Antiplatelet drug in pregnancy • Pharmacokinetics of Antiplatelet drug • |
| Genetics, Pharmacogenomics, and Proteinomics of Antiplatelet drug | Genetics of Antiplatelet drug • Pharmacogenomics of Antiplatelet drug • Proteomics of Antiplatelet drug |
| Newstories on Antiplatelet drug | Antiplatelet drug in the news • Be alerted to news on Antiplatelet drug • News trends on Antiplatelet drug |
| Commentary on Antiplatelet drug | Blogs on Antiplatelet drug |
| Patient Resources on Antiplatelet drug | Patient resources on Antiplatelet drug • Discussion groups on Antiplatelet drug • Patient Handouts on Antiplatelet drug • Directions to Hospitals Treating Antiplatelet drug • Risk calculators and risk factors for Antiplatelet drug |
| Healthcare Provider Resources on Antiplatelet drug | Symptoms of Antiplatelet drug • Causes & Risk Factors for Antiplatelet drug • Diagnostic studies for Antiplatelet drug • Treatment of Antiplatelet drug |
| Continuing Medical Education (CME) Programs on Antiplatelet drug | CME Programs on Antiplatelet drug |
| International Resources on Antiplatelet drug | Antiplatelet drug en Espanol • Antiplatelet drug en Francais |
| Business Resources on Antiplatelet drug | Antiplatelet drug in the Marketplace • Patents on Antiplatelet drug |
| Informatics Resources on Antiplatelet drug | List of terms related to Antiplatelet drug |
| ||||
Acknowledgement and Attribution Regarding Sources of Content
Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .

